Clinical trialNCT01459965CompletedInterventional

Stenting Malignant Jaundice for Quality of Life

SponsorIndiana UniversityEnrollment164Bile Duct Neoplasms Malignant

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Endoscopic stent insertion is considered the method of choice for palliation of malignant bile duct obstruction (MBDO). However, it can cause complications and requires periodic stent exchanges. While endoscopic stenting is clearly indicated for relief of cholangitis or refractory pruritus, its role in patients with jaundice alone is less clear. Endoscopic stenting for this relative indication might be justified, if there is a significant improvement in quality of life (QOL) of such patients. The aim of the investigators study was to determine whether endoscopic stenting for MBDO results in improved QOL.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Douglas Howell, MD
MaineHealth
Principal Investigator
clinicaltrials.gov ↗
Glen A Lehman, MD
Indiana Univesity Medical Center
Principal Investigator
clinicaltrials.gov ↗
James Frankes, MD
Rockford GE Associates
Principal Investigator
clinicaltrials.gov ↗
John Johanson, MD
Rockford GE Associates
Principal Investigator
clinicaltrials.gov ↗
Stuart Sherman, MD
Indiana University Medical Center
Principal Investigator
clinicaltrials.gov ↗
Tahir Qaseem, MD
MaineHealth
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Jul 1993
Primary completion: 30 Nov 2004
Completion: 30 Nov 2004
Last update posted: 26 Oct 2011
Registered enrollment: 164
Registry id: NCT01459965

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.